HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Avery Selected Research

Robert L Avery Research Topics

Disease

12Macular Degeneration (Age-Related Maculopathy)
01/2022 - 03/2006
9Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 10/2006
9Macular Edema
10/2017 - 03/2006
4Retinal Vein Occlusion
10/2017 - 04/2007
3Choroidal Neovascularization
08/2019 - 03/2006
3Endophthalmitis (Ophthalmia)
12/2014 - 11/2006
2Retinopathy of Prematurity (Retrolental Fibroplasia)
07/2020 - 02/2012
2Blindness (Hysterical Blindness)
07/2020 - 01/2018
2Inflammation (Inflammations)
04/2019 - 02/2007
2Diabetes Mellitus
04/2017 - 10/2006
2Epiretinal Membrane (Epiretinal Membranes)
04/2017 - 09/2007
2Edema (Dropsy)
12/2016 - 06/2011
2Retinal Perforations
06/2015 - 09/2011
2Retinal Detachment (Retinal Detachments)
01/2015 - 06/2004
2Hemorrhage
06/2011 - 02/2007
2Retinal Hemorrhage
10/2008 - 02/2007
1Geographic Atrophy
01/2022
1Ischemia
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Hyperglycemia
01/2019
1Hypertension (High Blood Pressure)
12/2016
1Stroke (Strokes)
01/2016
1Myocardial Infarction
01/2016
1Vascular Diseases (Vascular Disease)
01/2016
1Open-Angle Glaucoma (Glaucoma, Open Angle)
04/2015
1Ocular Hypertension (Glaucoma, Suspect)
04/2015
1Infections
12/2014
1Retinal Diseases
06/2014
1Pain (Aches)
11/2013
1Proliferative Vitreoretinopathy
09/2007
1Papilledema
02/2007
1Brain Edema (Cerebral Edema)
02/2007
1Pathologic Neovascularization
11/2006
1Uveitis
11/2006
1Anterior Uveitis
09/2006
1Hyperoxia
06/2004

Drug/Important Bio-Agent (IBA)

12Bevacizumab (Avastin)FDA Link
10/2017 - 03/2006
11Ranibizumab (Lucentis)FDA Link
08/2019 - 11/2006
8Retinaldehyde (Retinal)IBA
01/2022 - 10/2006
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 11/2006
5afliberceptIBA
08/2019 - 12/2014
3Fluorescein (Funduscein)FDA LinkGeneric
10/2013 - 10/2006
3Biological ProductsIBA
10/2008 - 03/2006
2paryleneIBA
12/2021 - 01/2018
2microplasminIBA
04/2017 - 06/2015
2Pharmaceutical PreparationsIBA
10/2013 - 02/2012
2VimentinIBA
09/2007 - 06/2004
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2019
1CytokinesIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
01/2019
1Retinal Pigments (Pigments, Visual)IBA
01/2018
1LipidsIBA
12/2016
1hydroxide ionIBA
04/2015
1GlucocorticoidsIBA
04/2015
1MucinsIBA
04/2015
1SteroidsIBA
04/2015
1Aerosolized Particles and DropletsIBA
12/2014
1Anti-Bacterial Agents (Antibiotics)IBA
12/2014
1AntibodiesIBA
09/2007
1Glial Fibrillary Acidic ProteinIBA
09/2007
1Laminin (Merosin)IBA
09/2007
1Neurofilament ProteinsIBA
09/2007
1Bradykinin Receptors (Bradykinin Receptor)IBA
02/2007
1PrekallikreinIBA
02/2007
1Kallikreins (Kallikrein)IBA
02/2007
1Proteins (Proteins, Gene)FDA Link
02/2007
1Complement C1 (Complement 1)IBA
02/2007
1ProteomeIBA
02/2007
1Carbonic Anhydrase IIBA
02/2007
1Neutralizing AntibodiesIBA
02/2007
1Intermediate Filament ProteinsIBA
06/2004
1Oxygen (Dioxygen)IBA
06/2004

Therapy/Procedure

3Vitrectomy
04/2019 - 09/2007
3Intravitreal Injections
04/2017 - 09/2006
3Therapeutics
01/2016 - 06/2004
3Injections
01/2016 - 10/2008
2Traction
04/2017 - 06/2015
1Glycemic Control
01/2019
1Lasers (Laser)
12/2016
1Light Coagulation
12/2016
1Photochemotherapy (Photodynamic Therapy)
01/2012
1Endotamponade
09/2011
1Aftercare (After-Treatment)
06/2011